Director, Duke Center for Autism & Brain Development
William Cleland Distinguished Professor
Geraldine Dawson is the William Cleland Distinguished Professor of Psychiatry and Behavioral Sciences at Duke University, where she also is Professor of Pediatrics and Psychology & Neuroscience. Dawson is the Director of the Duke Institute for Brain Sciences whose mission is to promote interdisciplinary brain science and translate discoveries into solutions for health and society. Dawson also is Director of the Duke Center for Autism and Brain Development, an NIH Autism Center of Excellence, which is an interdisciplinary research program and clinic, aimed to improve the lives of those with autism through research, education, clinical services, and policy. Dawson is Associate Director of the Marcus Center for Cellular Cures which aims to discover cellular treatments that can improve outcomes and quality of life for individuals with autism. Dawson received a Ph.D. in Developmental and Child Clinical Psychology from the University of Washington and completed a clinical internship at the UCLA Neuropsychiatric Institute.
Dawson previously served as President of the International Society for Autism Research and was appointed by the US Secretary of Health as a member of the NIH Interagency Autism Coordinating Committee (IACC) which develops the federal strategic plan for autism research, services, and policy. Dawson was Founding Director of the University of Washington (UW) Autism Center and the Duke Center for Autism and Brain Development, Dawson was awarded the American Psychological Association Distinguished Career Award (Div53); Association for Psychological Science Lifetime Achievement Award; Clarivate Top 1% Cited Researcher Across All Scientific Fields; NIH Top Research Advances of the Year Award (2007, 2008, 2009, 2010, 2012, 2013, 2015, 2016, 2017, 2018); Autism Society of America Award for Research Contributions; Autism Society Medical Professional of the Year; and Autism Society Award for Valuable Service. Dawson is a Fellow of the American Psychological Society and American Psychological Association, and is Associate Editor or on editorial boards of four scientific journals.
Distinguished Career Award. American Psychological Association. August 09, 2019
Novel Approaches to Infant Screening for ASD in Pediatric Primary Care awarded by National Institutes of Health (Principal Investigator). 2019 to 2024
Scalable Computational Platform For Active Closed-Loop Behavioral Coding in Autism Spectrum Disorder awarded by National Institutes of Health (Co-Principal Investigator). 2019 to 2023
Duke CTSA (TL1) awarded by National Institutes of Health (Mentor). 2018 to 2023
Co-occurring ADHD in young children with ASD: Precursors, detection, neural signatures, and early treatment awarded by National Institutes of Health (Principal Investigator). 2017 to 2022
Marcus Foundation Phase II MSC ASD awarded by (Co-Principal Investigator). 2019 to 2022
Digital Behavioral Outcome Measures for Autism awarded by (Co-Principal Investigator). 2019 to 2022
Tailoring treatment targets for early autism intervention in Africa awarded by National Institutes of Health (Co Investigator). 2019 to 2021
Duke Expanded Access Protocol Proposal for the Cord Blood Association Foundation awarded by (Principal Investigator). 2020
Pilot Study to Improve Access to Early Intervention for Autism in Africa awarded by National Institutes of Health (Mentor). 2015 to 2020
1/5-The Autism Biomarkers Consortium for Clinical Trials awarded by Yale University (Principal Investigator). 2015 to 2020
Filipek, P. A., et al. “The screening and diagnosis of autistic spectrum disorders.” The Science of Mental Health: Volume 2: Autism, 2013, pp. 11–56.
Minshew, N. J., et al. “Neuropsychology and neurophysiology of autism spectrum disorders.” Understanding Autism: From Basic Neuroscience to Treatment, 2006, pp. 379–415.
Dawson, Geraldine, et al. “Author Correction: Atypical postural control can be detected via computer vision analysis in toddlers with autism spectrum disorder.” Sci Rep, vol. 10, no. 1, Jan. 2020, p. 616. Pubmed, doi:10.1038/s41598-020-57570-1. Full Text
Rogers, Sally J., et al. “A Multisite Randomized Controlled Two-Phase Trial of the Early Start Denver Model Compared to Treatment as Usual.” J Am Acad Child Adolesc Psychiatry, vol. 58, no. 9, Sept. 2019, pp. 853–65. Pubmed, doi:10.1016/j.jaac.2019.01.004. Full Text
Sabatos-DeVito, Maura, et al. “Methodological considerations in the use of Noldus EthoVision XT video tracking of children with autism in multi-site studies.” Biol Psychol, vol. 146, Sept. 2019, p. 107712. Pubmed, doi:10.1016/j.biopsycho.2019.05.012. Full Text
Franz, Lauren, and Geraldine Dawson. “Implementing early intervention for autism spectrum disorder: a global perspective.” Pediatr Med, vol. 2, Aug. 2019. Pubmed, doi:10.21037/pm.2019.07.09. Full Text Open Access Copy
Davlantis, Katherine S., et al. “A novel method for measuring learning opportunities provided by parents to young children with autism spectrum disorder.” Autism, vol. 23, no. 6, Aug. 2019, pp. 1563–74. Pubmed, doi:10.1177/1362361318817303. Full Text
Carpenter, Kimberly L. H., et al. “Sensory Over-Responsivity: An Early Risk Factor for Anxiety and Behavioral Challenges in Young Children.” J Abnorm Child Psychol, vol. 47, no. 6, June 2019, pp. 1075–88. Pubmed, doi:10.1007/s10802-018-0502-y. Full Text
Amaral, David G., et al. “Gaps in Current Autism Research: The Thoughts of the Autism Research Editorial Board and Associate Editors.” Autism Res, vol. 12, no. 5, May 2019, pp. 700–14. Pubmed, doi:10.1002/aur.2101. Full Text
Yerys, Benjamin E., et al. “Brief Report: Pilot Study of a Novel Interactive Digital Treatment to Improve Cognitive Control in Children with Autism Spectrum Disorder and Co-occurring ADHD Symptoms.” J Autism Dev Disord, vol. 49, no. 4, Apr. 2019, pp. 1727–37. Pubmed, doi:10.1007/s10803-018-3856-7. Full Text
Campbell, Kathleen, et al. “Computer vision analysis captures atypical attention in toddlers with autism.” Autism : The International Journal of Research and Practice, vol. 23, no. 3, Apr. 2019, pp. 619–28. Epmc, doi:10.1177/1362361318766247. Full Text
Naples, Adam, et al. “EEG AND PUPILLARY RESPONSE IN CHILDREN WITH AUTISM: RESULTS FROM THE AUTISM BIOMARKERS CONSORTIUM FOR CLINICAL TRIALS INTERIM ANALYSIS.” Psychophysiology, vol. 56, WILEY, 2019, pp. S20–S20.
Ressler, B., et al. “Meeting the demands of msc production for clinical studies.” Cytotherapy, vol. 21, no. 5, Elsevier BV, 2019, pp. S81–82. Crossref, doi:10.1016/j.jcyt.2019.03.496. Full Text
Kurtzberg, J., et al. “MANUFACTURING OF ALLOGENEIC HUMAN CORD TISSUE MESENCHYMAL STROMAL CELLS: INITIAL RESULTS OF A PHASE I CLINICAL TRIAL IN CHILDREN WITH AUTISM SPECTRUM DISORDER.” Cytotherapy, vol. 20, no. 5, ELSEVIER SCI LTD, 2018, pp. S44–S44.
Li, Y., et al. “Extracting relationships by multi-domain matching.” Advances in Neural Information Processing Systems, vol. 2018-December, 2018, pp. 6798–809.
Carpenter, Kimberly, et al. “Phase I Open Label Trial of Autologous Cord Blood for Treatment of Autism: Correlations Between Behavioral Improvement and Increased White Matter Connectivity in Children With Autism.” Neuropsychopharmacology, vol. 42, NATURE PUBLISHING GROUP, 2017, pp. S495–96.
Pandina, G., et al. “Prospective, observational cohort study of JAKE (TM), an autism knowledge.” European Neuropsychopharmacology, vol. 27, ELSEVIER SCIENCE BV, 2017, pp. S1118–S1118.
Li, Y., et al. “Targeting EEG/LFP synchrony with neural nets.” Advances in Neural Information Processing Systems, vol. 2017-December, 2017, pp. 4621–31.
Neuhaus, Emily, et al. “FACE PROCESSING AND PARENT ANXIETY DURING EARLY CHILDHOOD INTERACT TO PREDICT ADOLESCENT ANXIETY IN AUTISM SPECTRUM DISORDER.” Psychophysiology, vol. 52, WILEY-BLACKWELL, 2015, pp. S101–S101.